Hasil Pencarian - Heidar Sharafi

  • Menampilkan 1 - 19 hasil dari 19
Perbaiki Hasil
  1. 1
    Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment

    Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment oleh Heidar Sharafi, Seyed Moayed Alavian

    Diterbitkan 2015-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

    Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis oleh Abdolhalim Rajabi, Heidar Sharafi, Seyed Moayed Alavian

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients?

    What is the ethnicity-specific impact of genetic polymorphisms on the response to hepatitis C treatment in an admixed population of Brazilian patients? oleh Maryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi

    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    HBV Infection Trend in Iranian Disabled Children; Is It really Worrying?

    HBV Infection Trend in Iranian Disabled Children; Is It really Worrying? oleh Mohammad Hossein Khosravi, Heidar Sharafi, Seyed Moayed Alavian

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C

    The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C oleh Maryam Keshvari, Seyed Moayed Alavian, Bita Behnava, Ali Pouryasin, Heidar Sharafi

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Effect of seasonal changes on the prevalence of uropathogens in 2010-2011and determination of antibiotic resistance pattern of Escherichia coli in three neighbor cities; Shiraz, Marvdasht and Saadat-Shahr

    Effect of seasonal changes on the prevalence of uropathogens in 2010-2011and determination of antibiotic resistance pattern of Escherichia coli in three neighbor cities; Shiraz, Ma... oleh Mohammad Pouryasin, Marjan Shaheli, Masoume Rahmani, Tannaz Heidarzadeh, Heidar Sharafi, Mohammad Farvardin

    Diterbitkan 2014-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding Disorders

    Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding Disorders oleh Azar Gharoonpour, Saeideh Maleki, Hamid Sharifi, Seyedehsara Osia, Heidar Sharafi, Maryam Keshvari

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers

    Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers oleh Roya Rashti, Heidar Sharafi, Seyed Moayed Alavian, Yousef Moradi, Amjad Mohamadi Bolbanabad, Ghobad Moradi

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Distribution of Human Papillomavirus Genotypes in Liquid-based Samples; Abundance of HPV-53 in Tehran, Iran.

    Distribution of Human Papillomavirus Genotypes in Liquid-based Samples; Abundance of HPV-53 in Tehran, Iran. oleh Mohammad Pouryasin, Heidar Sharafi, Azam-Sadat Mousavi, Shakiba Khodadad, Mahtab Marjani, Fereshteh Jamshidi, Ali Pouryasin

    Diterbitkan 2014-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019

    Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019 oleh Ghobad Moradi, Seyed Moayed Alavian, Fatemeh Gholami, Rashid Ramezani, Leila Ahangarzadeh, Yousef Moradi, Heidar Sharafi

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

    Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study oleh Seyed Moayed Alavian, Mohammad Tasavon Gholamhoseini, Heidar Sharafi, Helena HL Borba, Asma Sabermahani, Behzad Hajarizadeh

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis

    Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis oleh Mohammad Saeid Rezaee-Zavareh, Khashayar Hesamizadeh, Bita Behnava, Seyed Moayed Alavian, Mohammad Gholami-Fesharaki, Heidar Sharafi

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients

    First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients oleh Zahra Hasanshahi, Ava Hashempour, Farzane Ghasabi, Javad Moayedi, Zahra Musavi, Behzad Dehghani, Heidar Sharafi, Hassan Joulaei

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study

    Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study oleh Heidar Sharafi, Seyed Hoda Alavian, Bita Behnava, Mohammad Saeid Rezaee-Zavareh, Mehri Nikbin, Seyed Moayed Alavian

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

    Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders oleh Heidar Sharafi, Bita Behnava, Alireza Azizi-saraji, Ali Namvar, Ali Anvar, Shima Salimi, Seyed Moayed Alavian

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection

    Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection oleh Pooneh Rahimi, Heidar Sharafi, Golnaz Bahramali, FaridehSadat SajadianFard, Nafiseh Sadat Asadi, Seyed Moayed Alavian, Vahid Iranpur Mobarakeh, Seyedeh Zahra Moravej

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran

    Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran oleh Ghazal Mousavian, Nima Ghalekhani, Fatemeh Tavakoli, Willi McFarland, Armita Shahesmaeili, Heidar Sharafi, Mehrdad Khezri, Soheil Mehmandoost, Jasem Zarei, Hamid Sharifi, Ali Mirzazadeh

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study

    Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study oleh Soheil Mehmandoost, Ali Mirzazadeh, Mohammad Karamouzian, Mehrdad Khezri, Heidar Sharafi, Armita Shahesmaeili, Saiedeh Haji Maghsoudi, Nima Ghalekhani, Fatemeh Tavakoli, Maliheh Sadat Bazrafshani, Mostafa Shokoohi, Niloufar Aghaali, Ali Akbar Haghdoost, Hamid Sharifi

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era

    Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era oleh Sanam Hariri, Heidar Sharafi, Mahdi Sheikh, Shahin Merat, Farnaz Hashemi, Fatemeh Azimian, Babak Tamadoni, Rashid Ramazani, Mohammad Mehdi Gouya, Behzad Abbasi, Mehrzad Tashakorian, Ramin Alasvand, Seyed Moayed Alavian, Hossein Poustchi, Reza Malekzadeh

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: